JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol.48, no.11, pp.2258-2262, 2006 (SCI-Expanded)
OBJECTIVES The aim of this study was to determine the protective effect of carvedilol in anthracycline (ANT)-induced cardiornyopathy (CMP).